Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

$ino $10.99 v -0.25 (-2.22%)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Taurus69 Member Profile
Member Level 
Followed By 175
Posts 25,494
Boards Moderated 166
Alias Born 08/30/12
160x600 placeholder
INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its DNA Medicine to Treat a Rare Disease R... PR Newswire (US) - 11/23/2020 8:00:00 AM
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® ... PR Newswire (US) - 11/20/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 4:07:28 PM
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-48... PR Newswire (US) - 11/16/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 4:22:51 PM
INOVIO Reports Third Quarter 2020 Financial Results PR Newswire (US) - 11/9/2020 4:05:00 PM
INOVIO to Report Third Quarter 2020 Financial Results on November 9, 2020 PR Newswire (US) - 10/26/2020 8:00:00 AM
Danger Is Approaching for Coronavirus Vaccine Stocks -- Heard on the Street Dow Jones News - 9/29/2020 3:42:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/28/2020 5:29:47 PM
INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800 PR Newswire (US) - 9/28/2020 7:00:00 AM
Inovio Shares Up After Adding Thermo Fisher as Manufacturer for Vaccine Candidate Dow Jones News - 9/9/2020 10:47:00 AM
INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium PR Newswire (US) - 9/8/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2020 4:49:13 PM
INOVIO to Present at Upcoming Investor Conferences in September PR Newswire (US) - 9/1/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 7:00:06 PM
INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update PR Newswire (US) - 8/10/2020 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2020 7:12:57 PM
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with... PR Newswire (US) - 7/30/2020 8:00:00 AM
INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory P... PR Newswire (US) - 7/29/2020 7:30:00 AM
INOVIO to Report Second Quarter 2020 Financial Results on August 10, 2020 PR Newswire (US) - 7/27/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 7:01:00 PM
Correction to Poor Performance of Health-Care Stocks Article Dow Jones News - 7/5/2020 6:43:00 PM
Coronavirus Is No Cure for Health-Care Stocks Dow Jones News - 7/5/2020 5:17:00 PM
Coronavirus Is No Cure for Health-Care Stocks Dow Jones News - 7/5/2020 8:29:00 AM
INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19 PR Newswire (US) - 6/30/2020 7:30:00 AM
Taurus69 Member Level  Sunday, 10/25/20 06:53:47 PM
Re: None
Post # of 34762 
$ino $10.99 v -0.25 (-2.22%)
Volume: 4,109,413 @10/23/20 7:59:18 PM EDT

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences